Cargando…
A young child with pediatric multisystem inflammatory syndrome successfully treated with high-dose immunoglobulin therapy
Pediatric multisystem inflammatory syndrome (MIS-C) is a disease that presents mainly in older children after coronavirus disease 2019 (COVID-19) and is associated with Kawasaki-like symptoms and multiple-organ failure. The number of cases of MIS-C has increased since April 2020, with reports mainly...
Autores principales: | Mohri, Yosuke, Shimizu, Mariko, Fujimoto, Tadao, Nishikawa, Yuki, Ikeda, Akiko, Matsuda, Yusuke, Wada, Taizo, Kawaguchi, Chiharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969449/ https://www.ncbi.nlm.nih.gov/pubmed/35382510 http://dx.doi.org/10.1016/j.idcr.2022.e01493 |
Ejemplares similares
-
Multisystem inflammatory syndrome in a young adult successfully treated with plasmapheresis, immunoglobulins, and corticosteroids: a case report
por: Sreckovic, Miodrag, et al.
Publicado: (2022) -
Immunoglobulin, glucocorticoid, or combined therapy for multisystem inflammatory syndrome in children
por: Chew, Christine, et al.
Publicado: (2023) -
Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child
por: Yamaguchi, Yohei, et al.
Publicado: (2022) -
The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease
por: Marco, Helena, et al.
Publicado: (2014) -
Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin
por: Yoshioka, Katsunobu, et al.
Publicado: (2018)